SANTA CLARA, California, Nov. 8 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release: Agilent Technologies Inc. (NYSE: A) has become a member of How2Recycle(R), a standardized labeling system owned by Delaware nonprofit Green Blue Institute, Inc. The program involves a coalition of forward-thinking brands who want their packaging to be recycled and are empowering consumers to do it through smart packagi more PR

WILMINGTON, Delaware, Nov. 7 (TNSres) -- AstraZeneca, a biopharmaceutical company, issued the following news release: AstraZeneca, a leader in cardiorenal research, presented new data at the American Society of Nephrology (ASN) Kidney Week 2022 in Orlando, Florida, US on the importance of earlier screening and diagnosis of chronic kidney disease (CKD) and the impact of FARXIGA(R) (dapagliflozin) on reducing healthcare costs./1,/2 These findings were also simultaneously published in the Journal  more PR

WILMINGTON, Delaware, Nov. 8 (TNSjou) -- AstraZeneca, a biopharmaceutical company, issued the following news release on Nov. 7, 2022: * * * - Results presented at American Heart Association (AHA) Scientific Sessions 2022 and being published in the Journal of the American College of Cardiology - Clinical benefits were observed within two weeks with FARXIGA, highlighting the importance of early treatment initiation * * * New findings from a pre-specified analysis of DELIVER Phase III trial da more PR

WILMINGTON, Delaware, Nov. 12 (TNSjou) -- AstraZeneca, a biopharmaceutical company, issued the following news release: AstraZeneca's IMFINZI(R) (durvalumab) in combination with IMJUDO(R) (tremelimumab) plus platinum-based chemotherapy has been approved in the US for the treatment of adult patients with Stage IV (metastatic) non-small cell lung cancer (NSCLC). The approval by the Food and Drug Administration (FDA) was based on the results from the POSEIDON Phase III trial. Patients treated with more PR

WILMINGTON, Delaware, Nov. 10 -- AstraZeneca, a biopharmaceutical company, issued the following news release: The Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) has voted 16 to 1 that the data support a favorable benefit risk assessment for the use of PT027 (albuterol/budesonide) for the treatment of asthma in people aged 18 years and older. In adolescents aged 12 to 17 years, the Committee voted 9 to 8 that the data do not support a favorable benefit ri more PR

DOVER, Delaware, Nov. 8 -- Delaware Attorney General Kathy Jennings issued the following news release on Nov. 7, 2022: Attorney General Jennings today announced a multistate settlement with Experian Data Corp ("EDC") for failing to warn affected consumers after it learned that an identity thief was posing as a private investigator and retrieving sensitive personal information from Court Ventures Inc., a database that EDC had purchased. In 2012, the U.S. Secret Service notified EDC of the exist more PR

DOVER, Delaware, Nov. 8 -- Delaware Attorney General Kathy Jennings issued the following news release on Nov. 7, 2022: Attorney General Kathleen Jennings announced today that Delaware, along with 39 states, has obtained two multistate settlements with Experian Information Solutions, Inc. ("Experian") and T-Mobile USA, Inc. ("T-Mobile") concerning a 2015 data breach experienced by Experian that compromised the personal information of more than 15 million individuals who submitted credit applicat more PR

DELAWARE, Ohio, Nov. 10 (TNSres) -- Ohio Wesleyan University issued the following news release: Ohio Wesleyan University is launching a new OWU Community Research Fellows program this fall to link student-researchers with local organizations seeking to complete special projects. "The idea is to get students working on projects for businesses, nonprofits, and government organizations in the community," said Robert Gitter, Ph.D., OWU professor emeritus of Economics. Gitter helped to design the  more PR